Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R. Bellamy N, et al. Among authors: raynauld jp. Osteoarthritis Cartilage. 2005 Feb;13(2):104-10. doi: 10.1016/j.joca.2004.10.016. Osteoarthritis Cartilage. 2005. PMID: 15694571 Free article. Clinical Trial.
BLISS index for analyzing knee osteoarthritis trials data.
Bellamy N, Bell MJ, Pericak D, Goldsmith CH, Torrance GW, Raynauld JP, Walker V, Tugwell P, Polisson R. Bellamy N, et al. Among authors: raynauld jp. J Clin Epidemiol. 2007 Feb;60(2):124-32. doi: 10.1016/j.jclinepi.2006.04.004. Epub 2006 Aug 30. J Clin Epidemiol. 2007. PMID: 17208118
Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P. Raynauld JP, et al. Osteoarthritis Cartilage. 2005 Feb;13(2):111-9. doi: 10.1016/j.joca.2004.10.018. Osteoarthritis Cartilage. 2005. PMID: 15694572 Free article. Clinical Trial.
OBJECTIVE: To compare the effectiveness and safety of repeat treatment with hylan G-F 20 based on data from a randomized, controlled trial [Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outc …
OBJECTIVE: To compare the effectiveness and safety of repeat treatment with hylan G-F 20 based on data from a randomized, controlled trial [ …
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.
Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P; Canadian Knee OA Study Group. Torrance GW, et al. Among authors: raynauld jp. Osteoarthritis Cartilage. 2002 Jul;10(7):518-27. doi: 10.1053/joca.2001.0513. Osteoarthritis Cartilage. 2002. PMID: 12127831 Free article. Clinical Trial.
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO 3rd, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier JP, Raynauld JP, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF. Bingham CO 3rd, et al. Among authors: raynauld jp. Arthritis Rheum. 2006 Nov;54(11):3494-507. doi: 10.1002/art.22160. Arthritis Rheum. 2006. PMID: 17075851 Free article. Clinical Trial.
110 results